E. Ohman J:Or Asset Management Ab Moderna, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Apr 05, 2024	SELL	$129.91 - $234.98 $7.24 Million - $13.1 Million	-55,700 Closed	0 $0
Q1 2021 Apr 05, 2024	BUY	$109.18 - $185.98 $1.32 Million - $2.25 Million	12,100 Added 27.75%	55,700 $7.29 Billion
Q4 2020 Apr 05, 2024	SELL	$65.74 - $169.86 $1.54 Million - $3.99 Million	-23,500 Reduced 35.02%	43,600 $4.55 Billion
Q3 2020 Apr 05, 2024	SELL	$54.34 - $94.85 $309,738 - $540,645	-5,700 Reduced 7.83%	67,100 $4.75 Billion
Q2 2020 Apr 05, 2024	BUY	$29.67 - $80.0 $551,862 - $1.49 Million	18,600 Added 34.32%	72,800 $4.67 Billion
Q1 2020 Apr 05, 2024	BUY	$17.78 - $31.58 $51,562 - $91,582	2,900 Added 5.65%	54,200 $1.62 Billion
Q4 2019 Apr 05, 2024	BUY	$13.93 - $21.28 $157,409 - $240,464	11,300 Added 28.25%	51,300 $1 Billion
Q3 2019 Apr 05, 2024	BUY	$12.26 - $18.07 $490,400 - $722,800	40,000 New	40,000 $637 Million

1,112

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.